SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

JACC Clin Electrophysiol. 2024;10(6):1064-1074.

Clinical Impact of Early Rhythm Control and Healthy Lifestyles in Patients With Atrial Fibrillation.

, , , , ,

제1저자 이소령 · 교신저자 최의근

소속 (5)
  1. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  2. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: choiek17@snu.ac.kr.
  3. Department of Medical Statistics, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
  4. Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea.
  5. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Chest and Heart Hospital, Liverpool, United Kingdom; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Abstract

BACKGROUND There are limited data regarding the combined effect of early rhythm control (ERC) and healthy lifestyle (HLS) behaviors on the risk of ischemic stroke in patients with atrial fibrillation (AF).

OBJECTIVES This study sought to evaluate how the combination of ERC and HLS behaviors affects the risk of ischemic stroke in patients with AF.

METHODS Using the Korean National Health Insurance database, we included patients with new-onset AF between 2009 and 2016 (n = 208,662). Patients who received rhythm control therapy within 2 years after AF diagnosis were defined as the ERC group. Patients with ≥2 HLS behaviors were defined as the HLS group. Patients were categorized into 4 groups: group 1, without ERC and without HLS (n = 46,972); group 2, with HLS alone (n = 110,479); group 3, with ERC alone (n = 15,133); and group 4, with both ERC and HLS (n = 36,078). The primary outcome was ischemic stroke.

RESULTS Compared to group 1, group 2 and group 3 were associated with a lower risk of stroke (HR: 0.769 [95% CI: 0.728-0.881] and HR: 0.774 [95% CI: 0.703-0.852], respectively). Group 4 showed the lowest risk of stroke (HR: 0.575; 95% CI: 0.536-0.617). After propensity score weighting, the incorporation of additional ERC alongside HLS was associated with a relative risk reduction of 22% for stroke, and additional HLS alongside ERC were associated with a relative risk reduction of 27% for stroke.

CONCLUSIONS Each of ERC and HLS might reduce the risk of ischemic stroke in patients with new-onset AF. The presence of both ERC and HLS is associated with an enhanced benefit for stroke prevention in this population.

Copyright © 2024 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Keywords

atrial fibrillationlifestyle modificationrhythm controlstroke

Comment · 정정

Conflict of interest statement

Funding Support and Author Disclosures This research was supported in part by a grant from the Patient-Centered Clinical Research Coordinating Center funded by the Ministry of Health and Welfare, Republic of Korea (grant number HC21C0028), a Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT; the Ministry of Trade, Industry, and Energy; the Ministry of Health and Welfare; and the Ministry of Food and Drug Safety) (project numbers HI20C1662, 1711138358, and KMDF_PR_20200901_0173). Dr Choi has received research grants or speaking fees from Abbott, Bayer, BMS/Pfizer, Biosense Webster, Chong Kun Dang, Daewoong Pharmaceutical Co, Daiichi-Sankyo, DeepQure, Dreamtech Co Ltd, Jeil Pharmaceutical Co Ltd, Medtronic, Samjinpharm, Seers Technology, and Skylabs. Dr Lip has served as a consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, and Daiichi-Sankyo; no fees have been received personally. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

그 밖의 정보
출판 형태
Journal Article, Research Support, Non-U.S. Gov't
저널
JACC. Clinical electrophysiology · eISSN 2405-5018
전자 출판
2024-04-24
MeSH
Humans · Atrial Fibrillation* / epidemiology / physiopathology · Male · Female · Aged · Middle Aged · Republic of Korea / epidemiology · Ischemic Stroke* / prevention & control / epidemiology · Healthy Lifestyle* · Anti-Arrhythmia Agents / therapeutic use · Risk Factors · Stroke / prevention & control / epidemiology · Aged, 80 and over
Substances
Anti-Arrhythmia Agents